Sturm, Ruger & Company (RGR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
2024 net sales were $536 million, with diluted EPS of $1.77, both down from 2023 due to lower gross margin and profitability pressures.
Fourth quarter 2024 net sales were $146 million, with diluted EPS of $0.62, both up from the prior year’s Q4 and showing strong sequential improvement.
New product launches, including the RXM pistol and American Rifle Gen II, drove significant sales and market share gains.
Leadership transition announced: Todd Seyfert to become CEO in March 2025, ensuring continuity.
Board declared a $0.24 per share dividend for Q4, about 40% of net income.
Financial highlights
Gross margin declined from 25% in 2023 to 21% in 2024, mainly due to deleveraging, inflation, and product mix.
Cash and short-term investments totaled $105.5 million at year-end, with a current ratio of 4.2:1 and no debt.
Book value per share was $19.03, with $6.28 per share in cash and short-term investments.
Generated $56 million in cash from operations and invested $21 million in capital expenditures in 2024.
Net income for 2024 was $30.6 million, down from $48.2 million in 2023.
Outlook and guidance
Entering 2025 with a strong, debt-free balance sheet, reduced distributor inventories, and a robust pipeline of new products.
2025 capital expenditures expected to total $20 million.
Continued focus on disciplined pricing and long-term shareholder value creation.
Latest events from Sturm, Ruger & Company
- Board refresh and Ruger 2030 strategy drive strong returns and disciplined growth.RGR
Proxy filing24 Mar 2026 - Ruger’s board rebuffed Beretta’s control efforts, reinforcing governance and shareholder protections.RGR
Proxy Filing10 Mar 2026 - Beretta’s bid for board control prompts defensive measures and governance refreshment.RGR
Proxy Filing9 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Sales growth and innovation offset market declines, but profitability fell year-over-year.RGR
Q4 20252 Mar 2026 - Q2 sales and profit declined, but new products and efficiency gains support future growth.RGR
Q2 20242 Feb 2026 - Q3 2024 sales rose 1.2% to $122.3M, but EPS and net income declined on margin pressure.RGR
Q3 202417 Jan 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025